Hancock Whitney’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11M | Buy |
149,100
+2,388
| +2% | +$184K | 0.19% | 121 |
|
|
2025
Q4 | $11.6M | Buy |
146,712
+3,702
| +3% | +$292K | 0.21% | 108 |
|
|
2025
Q3 | $10.8M | Buy |
143,010
+133,573
| +1,415% | +$9.15M | 0.2% | 115 |
|
|
2025
Q2 | $651K | Buy |
9,437
+828
| +10% | +$54.3K | 0.01% | 509 |
|
|
2025
Q1 | $583K | Sell |
8,609
-314
| -4% | -$18.8K | 0.02% | 417 |
|
|
2024
Q4 | $401K | Sell |
8,923
-3,807
| -30% | -$214K | 0.01% | 478 |
|
|
2024
Q3 | $800K | Sell |
12,730
-221
| -2% | -$12.9K | 0.03% | 352 |
|
|
2024
Q2 | $765K | Sell |
12,951
-1,002
| -7% | -$62.7K | 0.03% | 347 |
|
|
2024
Q1 | $1.11M | Sell |
13,953
-375
| -3% | -$28.6K | 0.04% | 291 |
|
|
2023
Q4 | $1.13M | Sell |
14,328
-2,154
| -13% | -$153K | 0.04% | 290 |
|
|
2023
Q3 | $1.15M | Sell |
16,482
-8,500
| -34% | -$602K | 0.05% | 270 |
|
|
2023
Q2 | $1.73M | Sell |
24,982
-104,457
| -81% | -$7.43M | 0.07% | 216 |
|
|
2023
Q1 | $9.62M | Buy |
129,439
+2,149
| +2% | +$180K | 0.39% | 64 |
|
|
2022
Q4 | $11.9M | Sell |
127,290
-24,636
| -16% | -$2.38M | 0.46% | 52 |
|
|
2022
Q3 | $14.5M | Sell |
151,926
-3,097
| -2% | -$307K | 0.62% | 37 |
|
|
2022
Q2 | $14.4M | Buy |
155,023
+2,731
| +2% | +$267K | 0.57% | 41 |
|
|
2022
Q1 | $15.4M | Buy |
152,292
+114,790
| +306% | +$12.1M | 0.52% | 48 |
|
|
2021
Q4 | $3.87M | Sell |
37,502
-1,679
| -4% | -$155K | 0.12% | 138 |
|
|
2021
Q3 | $3.32M | Sell |
39,181
-9,353
| -19% | -$783K | 0.12% | 142 |
|
|
2021
Q2 | $4.05M | Buy |
48,534
+624
| +1% | +$51.1K | 0.13% | 136 |
|
|
2021
Q1 | $3.6M | Sell |
47,910
-5,850
| -11% | -$426K | 0.12% | 151 |
|
|
2020
Q4 | $3.67M | Buy |
53,760
+9,400
| +21% | +$611K | 0.12% | 146 |
|
|
2020
Q3 | $2.59M | Sell |
44,360
-1,785
| -4% | -$111K | 0.1% | 173 |
|
|
2020
Q2 | $3M | Sell |
46,145
-1,132
| -2% | -$71.3K | 0.11% | 156 |
|
|
2020
Q1 | $2.81M | Sell |
47,277
-4,127
| -8% | -$276K | 0.11% | 195 |
|
|
2019
Q4 | $3.82M | Sell |
51,404
-310
| -0.6% | -$21.8K | 0.12% | 203 |
|
|
2019
Q3 | $3.26M | Buy |
51,714
+11,548
| +29% | +$684K | 0.11% | 235 |
|
|
2019
Q2 | $2.19M | Sell |
40,166
-3,978
| -9% | -$214K | 0.07% | 285 |
|
|
2019
Q1 | $2.38M | Sell |
44,144
-7,587
| -15% | -$468K | 0.08% | 277 |
|
|
2018
Q4 | $3.39M | Buy |
51,731
+2,194
| +4% | +$164K | 0.11% | 231 |
|
|
2018
Q3 | $3.9M | Buy |
49,537
+26,824
| +118% | +$1.92M | 0.11% | 231 |
|
|
2018
Q2 | $1.46M | Sell |
22,713
-540
| -2% | -$35.6K | 0.07% | 267 |
|
|
2018
Q1 | $1.45M | Buy |
23,253
+2,194
| +10% | +$157K | 0.06% | 261 |
|
|
2017
Q4 | $1.53M | Sell |
21,059
-3,995
| -16% | -$290K | 0.06% | 260 |
|
|
2017
Q3 | $2.04M | Sell |
25,054
-1,900
| -7% | -$150K | 0.09% | 198 |
|
|
2017
Q2 | $2.17M | Buy |
+26,954
| New | +$2.13M | 0.09% | 203 |
|
|
2016
Q4 | – | Sell |
-2,312
| Closed | -$205K | – | 554 |
|
|
2016
Q3 | $205K | Buy |
+2,312
| New | +$218K | 0.01% | 489 |
|
|
2016
Q2 | – | Sell |
-1,953
| Closed | -$203 | – | 580 |
|
|
2016
Q1 | $203 | Sell |
1,953
-150,441
| -99% | -$14.6M | 0.01% | 497 |
|
|
2015
Q4 | $14.9M | Sell |
152,394
-51,168
| -25% | -$5.01M | 0.62% | 36 |
|
|
2015
Q3 | $19.6M | Sell |
203,562
-5,913
| -3% | -$622K | 0.82% | 5 |
|
|
2015
Q2 | $21.6M | Hold |
209,475
| – | – | 0.83% | 7 |
|
|
2015
Q1 | $21.6M | Sell |
209,475
-27,681
| -12% | -$2.8M | 0.83% | 7 |
|
|
2014
Q4 | $22.8M | Sell |
237,156
-23,085
| -9% | -$2.03M | 0.87% | 5 |
|
|
2014
Q3 | $20.7M | Sell |
260,241
-6,255
| -2% | -$493K | 0.79% | 9 |
|
|
2014
Q2 | $20.1M | Sell |
266,496
-3,364
| -1% | -$254K | 0.73% | 15 |
|
|
2014
Q1 | $20.2M | Buy |
269,860
+2,829
| +1% | +$200K | 0.79% | 10 |
|
|
2013
Q4 | $19.1M | Sell |
267,031
-12,615
| -5% | -$811K | 0.79% | 15 |
|
|
2013
Q3 | $15.9M | Sell |
279,646
-2,501
| -0.9% | -$149K | 0.73% | 35 |
|
|
2013
Q2 | $16.1M | Buy |
+282,147
| New | +$16.3M | 0.8% | 21 |
|
Other funds holding CVS
VCM
VPM
Hancock Whitney's CVS Position: Q1 2026 in Review
Hancock Whitney increased its CVS Health (CVS) stake by 1.6% in Q1 2026, buying an estimated $184K and bringing the position to 149,100 shares worth $11M. The position accounts for 0.19% of the portfolio, ranked #121.
Hancock Whitney first reported a position in CVS in Q2 2013 and has held it in 49 quarters since. The position peaked at $22.8M in Q4 2014. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Hancock Whitney held 149,100 shares of CVS Health worth $11M as of Q1 2026.
- Hancock Whitney bought 2,388 CVS Health shares in Q1 2026, an estimated $184K.
- CVS Health made up 0.19% of Hancock Whitney's portfolio in Q1 2026, its #121 holding.
- Hancock Whitney first reported a position in CVS Health in Q2 2013 and has held it in 49 quarters since.
- Hancock Whitney's CVS Health position peaked at $22.8M in Q4 2014.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Hancock Whitney's 13F filing for Q1 2026, filed 15 May 2026.